Clinical Assessment of a HYDRAGLYDE® Regimen

NCT03026257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2018-08-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate worn AIR OPTIX® plus HYDRAGLYDE® (AOHG) lenses cleaned and disinfected with HYDRAGLYDE® containing lens solutions compared to each of the control habitual silicone hydrogel (SiHy) lenses cleaned and disinfected with habitual multi-purpose solution (MPS) for cholesterol uptake.

Conditions

  • Refractive Errors
  • Myopia
  • Hypermetropia

Interventions

DEVICE

Lotrafilcon B contact lenses with added wetting agent

Silicone hydrogel contact lenses

DEVICE

Samfilcon A contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent

Multi-purpose disinfecting solution for contact lens care

DEVICE

Hydrogen peroxide-based contact lens solution with added wetting agent

Solution for contact lens cleaning and disinfecting

DEVICE

Senofilcon C contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

Senofilcon A contact lenses

Habitual silicone hydrogel contact lenses with a replacement pair issued after 2 weeks

DEVICE

Comfilcon A contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

Habitual Multi-Purpose Solution (HMPS)

Multi-purpose solution for contact lens care according to participant's habitual brand, used per manufacturer's instructions

Sponsors & Collaborators

  • Alcon, a Novartis Company

    lead INDUSTRY

Principal Investigators

  • Clinical Manager, Global Med Affairs, GCRA · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2017-08-18
Completion
2017-08-18
FDA Device
Yes

Countries

  • United States
  • Canada
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03026257 on ClinicalTrials.gov